Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians

Primary Care Diabetes

Volumn 4, Issue 3, 2010, Pages 187-192

  Nayak, B Shivananda ^a   Ramsingh, Deepak ^a   Gooding, Shanaree ^a   Legall, George ^a   Bissram, Sanjiv ^a   Mohammed, Atif ^a   Raychaudhuri, Anupama ^a   Sahadeo, Brad ^a   Pandohie, Varoon ^a   Figaro, Kemron ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

Adiponectin; Inflammation; Insulin resistance; Type 2 diabetes

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; TRINIDAD AND TOBAGO;

ADIPONECTIN; ADIPOSITY; ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; LINEAR MODELS; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; RISK ASSESSMENT; RISK FACTORS; TRINIDAD AND TOBAGO; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957327717     PISSN: 17519918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcd.2010.05.006     Document Type: Article

References (31)

1. Steadman's Online Medical Dictionary [article on internet], Lippincott Williams and Wilkins, Maryland, USA, available from: http://www.stedmans.com/ section.cfm/45.
2. International Diabetes Federation Diabetes Atlas 2nd ed. 2003 p. 51
3. C.E. Ezenwaka, and N.V. Offiah Differences in glycemic control and cardiovascular risk in primary care patients with type 2 diabetes in West Indies Clin. Exp. Med. 1 2001 91 98
4. M. Lexley Pinto Pereira, A. Hinds, I. Ali, R. Gooding, M. Ragbir, K. Samaroo, and B.S. Nayak Do current standards of primary care of diabetes meet with guideline recommendations in Trinidad, West Indies? Primary Care Diabetes 3 2009 91 96
5. C.E. Ezenwaka, and R. Kalloo Postprandial glucose control in Type 2 diabetic patients visiting two different primary care clinics in Trinidad, West Indies West Indian Med. J. 53 2004 392 399
6. C.E. Ezenwaka, and N.V. Offiah Abdominal obesity in Type 2 diabetic patients visiting primary healthcare clinics in Trinidad, West Indies Scand. J. Primary Health Care 20 2002 177 182
7. I.S. Gerald Cellular mechanisms of insulin resistance J. Clin. Invest. 106 4 2000 165 169
8. World Health Organization, Diabetes Facts and Figures [article on internet], World Health Organization [WHO], available from: http://www.who.int/ mediacentre/factsheets/fs312/en/.
9. M. Gulliford, D. Mahabir, B. Rocke, S. Chinn, and R. Rona Overweight, obesity and skinfold thicknesses of children of African or Indian descent in Trinidad and Tobago Int. J. Epidemiol. 30 5 2001 989 998
10. A. Barcelo, C. Aedo, S. Rajpathali, and S.S. Robles The cost of diabetes mellitus in Latin America and the Caribbean Bull. World Health Org. 81 1 2003 9 27
11. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome J. Clin. Invest. 116 2006 1784 1792
12. R.D. Lele, S.R. Joshi, and A. Gupte Association of adipocytokines (leptin, adiponectin TNF-α insulin and proinsulin with diabetes - the Mumbai Obesity Project [MOP] J. Assoc. Phys. India 54 2006 685 686
13. M.B. Schulze, E.B. Rimm, I. Shai, N. Rifai, and F.B. Hu Relationship between adiponectin, glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes Diabetes Care 27 2004 1680 1687
14. S Engeli, M. Feldpausch, K. Gorzelniak, F. Hartwig, U. Heintze, J. Janke, M. Möhlig, A. Pfeiffer, F.C. Luft, and A.M. Sharma Association between adiponectin and mediators of inflammation in obese women Diabetes 52 2003 942 947
15. S.B. Hully, S.R. Cummings, W.S. Browner, D.G. Grady, and N. Hearst Designing Clinical Research 2nd ed. 2006 Lippincott and Williams Baltimore, USA p. 32
16. R.R. Sokal, and F.J. Rohlf Biometry: The Principles and Practice of Statistics in Biological Research 3rd ed. 1995 W.H. Freeman New York
17. J.H. Zar Biostatistical Analysis 4th ed. 1999 Prentice Hall Upper Saddle River, NJ
18. Y.J. Hung, N.F. Chu, S.C. Wang, C.H. Hsieh, C.T. He, C.H. Lee, and S.C. Fan Correlation of plasma leptin and adiponectin with insulin sensitivity and beta-cell function in children - the Taipei Children Heart Study Int. J. Clin. Pract. 60 12 2006 1582 1587
19. J.V. Silha, M. Krsek, J.V. Skrha, P. Sucharda, B.L.G. Nyomba, and L.J. Murphy Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance Eur. J. Endocrinol. 149 2003 331 335
20. K Matsushita, H. Yatsuya, K. Tamakoshi, K. Wada, R. Otsuka, H. Zhang, K. Sugiura, T. Kondo, T. Murohara, and H. Toyoshima Inverse association between adiponectin and C-reactive protein in substantially healthy Japanese men Atherosclerosis 188 1 2005 184 189
21. CARICOM (Caribbean Community) Secretariat Report of the Caribbean Commission on Health and Development 2006 Ian Randle Publishers for the PAHO (Pan American Health Organization)/WHO (World Health Organization) Kingston, Jamaica
22. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
23. D.G. Hardie Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status Endocrinology 144 2003 5179 5183
24. T. Yamauchi, J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N.H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, and T. Kadowaki Cloning of adiponectin receptors that mediate anti-diabetic metabolic effects Nature 423 2003 762 769
25. I. Rakatzi, H. Mueller, O. Ritzeler, N. Tennagels, and J. Eckel Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1 Diabetologia 47 2004 249 258
26. D. Nemet, P. Wang, T. Funahashi, Y. Matsuzawa, S. Tanaka, L. Engelman, and D.M. Cooper Adipocytokines, body composition, and fitness in children Pediatr. Res. 53 2003 148 152
27. Y Arita, S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, J. Miyagawa, K. Hotta, I. Shimomura, T. Nakamura, K. Miyaoka, H. Kuriyama, M. Nishida, S. Yamashita, K. Okubo, K. Matsubara, M. Muraguchi, Y. Ohmoto, T. Funahashi, and Y. Matsuzawa Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem. Biophys. Res. Commun. 257 1999 79 83
28. S. Chamukuttan, M. Bheekamchand, M. Simon, V. Viswanathan, S.M. Haffner, and A. Ramachandran Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians Diabetes Care 26 2003 3226 3229
29. M.D.Li. Shanshan, H.J. Shin, E.L. Ding, and M.R. van Dam Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis J. Am. Med. Assoc. 302 2009 179 188
30. M. Shimabukuro, N. Higa, T. Asahi, Y. Oshiro, N. Takasu, T. Tagawa, S. Ueda, I. Shimomura, T. Funahashi, and Y. Matsuzawa Hypoadiponectinemia is closely linked to endothelial dysfunction in man J. Clin. Endocrinol. Metab. 88 2003 3236 3240
31. A. Pradhan Obesity metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders Nutr. Rev. 65 2007 152 156